New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/
Nephrology & Urology July 17,2024
New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/
Nephrology & Urology July 17,2024
The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

by Xia & He Publishing Inc.PRISMA flowchart for literature search and study selection, modified according to Page et al. Credit:Exploratory Research and Hypothesis in Medicine(2023). D
Oncology July 17,2024
The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

by Xia & He Publishing Inc.PRISMA flowchart for literature search and study selection, modified according to Page et al. Credit:Exploratory Research and Hypothesis in Medicine(2023). D
Oncology July 17,2024
New model could reduce reliance on chemotherapy

New model could reduce reliance on chemotherapy

byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast
Oncology July 17,2024
New model could reduce reliance on chemotherapy

New model could reduce reliance on chemotherapy

byAnglia Ruskin UniversityCredit: Unsplash/CC0 Public DomainA model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast
Oncology July 17,2024
Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C
Oncology July 17,2024
Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C
Oncology July 17,2024
Have fun in the sun, but protect your skin, expert says

Have fun in the sun, but protect your skin, expert says

by Carole Tanzer MillerRoughly 20% of Americans are diagnosed with skin cancer at some point in their lives, but it's not inevitable.Skin cancer is not only the most common cancer, it's also t
Oncology July 17,2024
Have fun in the sun, but protect your skin, expert says

Have fun in the sun, but protect your skin, expert says

by Carole Tanzer MillerRoughly 20% of Americans are diagnosed with skin cancer at some point in their lives, but it's not inevitable.Skin cancer is not only the most common cancer, it's also t
Oncology July 17,2024
Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

by Xia & He Publishing Inc.Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve
Oncology July 17,2024
Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

by Xia & He Publishing Inc.Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve
Oncology July 17,2024
Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and
Oncology July 17,2024
Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and
Oncology July 17,2024
Q&A: Patterns and prognostications in immune-related adverse events from immunotherapy treatment

Q&A: Patterns and prognostications in immune-related adverse events from immunotherapy treatment

by Liz Murphy,Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainYevgeniy Semenov, MD, MA, a physician-investigator in the Mass General Department of Dermatology and an Assistant Pro
Q & A July 17,2024
Q&A: Patterns and prognostications in immune-related adverse events from immunotherapy treatment

Q&A: Patterns and prognostications in immune-related adverse events from immunotherapy treatment

by Liz Murphy,Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainYevgeniy Semenov, MD, MA, a physician-investigator in the Mass General Department of Dermatology and an Assistant Pro
Q & A July 17,2024
Study reveals gene 'switched off' in early stages of pancreatic cancer allows rapid tumor growth and spread

Study reveals gene 'switched off' in early stages of pancreatic cancer allows rapid tumor growth and spread

byNottingham Trent UniversityHNF4A is methylated and suppressed in pancreatic cancer. Credit:Gastro Hep Advances(2024). DOI: 10.1016/j.gastha.2024.04.005Scientists at Nottingham Tren
Oncology July 17,2024
Study reveals gene 'switched off' in early stages of pancreatic cancer allows rapid tumor growth and spread

Study reveals gene 'switched off' in early stages of pancreatic cancer allows rapid tumor growth and spread

byNottingham Trent UniversityHNF4A is methylated and suppressed in pancreatic cancer. Credit:Gastro Hep Advances(2024). DOI: 10.1016/j.gastha.2024.04.005Scientists at Nottingham Tren
Oncology July 17,2024
Better together: Spatial arrangement of three immune cells is key to attacking tumors, study finds

Better together: Spatial arrangement of three immune cells is key to attacking tumors, study finds

by Matthew Tontonoz,Memorial Sloan Kettering Cancer CenterGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.05.025There's a frustrating fact about today&#39
Oncology July 17,2024
Better together: Spatial arrangement of three immune cells is key to attacking tumors, study finds

Better together: Spatial arrangement of three immune cells is key to attacking tumors, study finds

by Matthew Tontonoz,Memorial Sloan Kettering Cancer CenterGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.05.025There's a frustrating fact about today&#39
Oncology July 17,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com